Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Growth Hormone
Long-acting growth hormone releasing hormone analog for sustained GH and IGF-1 elevation.
Peptide B
Growth Hormone
The original GHRH analog and the first FDA-approved peptide secretagogue.
Typical vial
2 mg
Typical dose
100-300 mcg
Half-life
~30 minutes (no DAC) / 6-8 days (with DAC)
FDA status
Not FDA approved for human use.
Typical vial
5 mg
Typical dose
200-500 mcg
Half-life
~12 minutes
FDA status
Previously FDA approved (1997, as Geref) for pediatric GHD. …
CJC-1295 effects
Sermorelin effects
CJC-1295 side effects
Sermorelin side effects
CJC-1295 dosing ranges
Anti-aging and recovery (Mod GRF)
100 mcg · Once to three times daily (SubQ) · 8-12 weeks
Body composition (Mod GRF + Ipamorelin)
100-300 mcg · Two to three times daily · 8-12 weeks
CJC-1295 with DAC
1000-2000 mcg · Once or twice weekly · 8-12 weeks
Sermorelin dosing ranges
GH optimization / anti-aging
200-500 mcg · Once daily before bed (SubQ) · 3-6 months, then reassess
Combined with Ipamorelin
200-300 mcg of each · Once daily before bed · 3-6 months
Pediatric GHD (historical, prescribing-physician only)
30 mcg/kg · Once daily before bed · Per endocrinologist
CJC-1295: Long-acting growth hormone releasing hormone analog for sustained GH and IGF-1 elevation. Typical dose 100-300 mcg. Sermorelin: The original GHRH analog and the first FDA-approved peptide secretagogue. Typical dose 200-500 mcg. Both fall under the Growth Hormone category.
Stacking CJC-1295 with Sermorelin is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
CJC-1295 is typically dosed: Once to three times daily (SubQ) for Anti-aging and recovery (Mod GRF); Two to three times daily for Body composition (Mod GRF + Ipamorelin); Once or twice weekly for CJC-1295 with DAC. Sermorelin is typically dosed: Once daily before bed (SubQ) for GH optimization / anti-aging; Once daily before bed for Combined with Ipamorelin; Once daily before bed for Pediatric GHD (historical, prescribing-physician only).
CJC-1295: Not FDA approved for human use. Sermorelin: Previously FDA approved (1997, as Geref) for pediatric GHD. Brand discontinued 2008. Available in the US via compounding pharmacies on prescription.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free